Wells Fargo’s Coya Therapeutics COYA Stock Holding History
Bought
Maintained
Sold
Other funds holding COYA
ACM
CM
Wells Fargo's COYA Position: Q3 2026 in Review
Wells Fargo held its Coya Therapeutics (COYA) position steady in Q3 2026 at 500 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6365.
Wells Fargo first reported a position in COYA in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.92K in Q2 2026. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.
- Wells Fargo held 500 shares of Coya Therapeutics worth $2.5K as of Q3 2026.
- Wells Fargo left its Coya Therapeutics share count unchanged in Q3 2026.
- Coya Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6365 holding.
- Wells Fargo first reported a position in Coya Therapeutics in Q1 2023 and has held it in 8 quarters since.
- Wells Fargo's Coya Therapeutics position peaked at $2.92K in Q2 2026.
- 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.